Product Information

METFORMIN ER 500 MG GASTRC-TB is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.2781 per EA under NDC 50228044501. Its NADAC has been published 252 times since Sep 1, 2021.

METFORMIN ER 500 MG GASTRC-TB

Metformin Hydrochloride Extended-Release Tablets
$0.2781per EA

Strength

500 mg/1

NDC

50228044501

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

METFORMIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213334

On Market Since

4/16/2021

Pharmacological Classes

Biguanide
Biguanides

Price Statistics

The NADAC for METFORMIN ER 500 MG GASTRC-TB has been published 252 times since Sep 1, 2021, and over the history we have for it it has declined 86.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2781 per EA
All-time high$2.7019 (May 10, 2023)
All-time low$0.2781 (Jun 17, 2026)
52-week high$0.3965
52-week low$0.2781
Median price$0.6048
Average price$1.1177
Largest weekly change+107.3% (Feb 23, 2022)
Weeks tracked252
Tracking sinceSep 1, 2021

Price History

1W

0.0%

1M

-2.7%

3M

-1.0%

6M

-25.3%

1Y

-10.1%

3Y

-72.8%

5Y

N/A

All

-86.3%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 60% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 60%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of METFORMIN ER 500 MG GASTRC-TB?

The current National Average Drug Acquisition Cost (NADAC) for METFORMIN ER 500 MG GASTRC-TB, manufactured by ScieGen Pharmaceuticals, Inc., is $0.2781 per EA (NDC 50228044501), effective Jun 24, 2026.

How has the price of METFORMIN ER 500 MG GASTRC-TB changed over time?

Over the history we have for it, the NADAC for METFORMIN ER 500 MG GASTRC-TB has declined 86.3%. It has been tracked across 252 weekly CMS publications since Sep 1, 2021.

What are the highest and lowest recorded NADAC prices for METFORMIN ER 500 MG GASTRC-TB?

Since Sep 1, 2021, the NADAC for METFORMIN ER 500 MG GASTRC-TB has ranged from a low of $0.2781 (Jun 17, 2026) to a high of $2.7019 (May 10, 2023), with a median of $0.6048 per EA.

Are there cheaper alternatives to METFORMIN ER 500 MG GASTRC-TB?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, METFORMIN ER 500 MG OSMOTIC TB, is $0.1108 per EA — about 60% below METFORMIN ER 500 MG GASTRC-TB.

Who manufactures METFORMIN ER 500 MG GASTRC-TB?

METFORMIN ER 500 MG GASTRC-TB (NDC 50228044501) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.